InterventionsHuman trial

SAT-713 Phase 2 Clinical Trials Of Na-931 To Study Subjects Who Are Obese With At Least One Weight-related Comorbid Condition

ENDO 2025 Abstract

The paper

Tran L, Vu F, Tran ZV

ENDO 2025 Abstract · 22 Oct 2025 · CC BY-NC-ND

Presented at ENDO 2025

doi.org/10.1210/jendso/bvaf149.144

Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet · 4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026